TJX
37
-3
GE
58
-4
SIG
52
-2
GWW
39
-2
DRI
60
-7
TEL
58
-2
VFC
44
10
LB
55
-2
GPC
51
-2
MAC
37
-2
WHR
39
-4
CCI
47
-2
XYL
31
-2
CTAS
40
-2
EXPE
61
11
BEN
29
-4
AMG
50
-7
LNC
50
-2
BRK.B
47
5
FE
60
11
TJX
37
-3
GE
58
-4
SIG
52
-2
GWW
39
-2
DRI
60
-7
TEL
58
-2
VFC
44
10
LB
55
-2
GPC
51
-2
MAC
37
-2
WHR
39
-4
CCI
47
-2
XYL
31
-2
CTAS
40
-2
EXPE
61
11
BEN
29
-4
AMG
50
-7
LNC
50
-2
BRK.B
47
5
FE
60
11
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
30

BIO
Bio-Rad Laboratories

Last Price:
$254.68
Seasonality Move:
9.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.6B
Cash Flow: $81.2M
Price / Cash Flow: 25.98
Annual Sales: $234.52
Price / Book: 1.04

Profitability

EPS (TTM): -65.04000
Net Income (TTM): $-1.8B
Gross Margin: $1.4B
Return on Equity: -23.87%
Return on Assets: -16.9%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 41 years for BIO is 53.73%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.72% of Gross Profit Margin.
  • The Research & Development expenses have been 11.53% of Revenue.
  • The Net Earning history of BIO is -71.86% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 6.48
Quick Ratio: 4.53

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 21.75

BIO Technical Analysis vs Fundamental Analysis

Sell
30
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?